Your search for Antineoplastic and immunomodulating agents
Number of alerts found: 111

2023/0491 - POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS]

POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS] POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491 - POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000305
Publication:
July 16, 2025, 8:28 a.m.
2023/0481-SACITUZUMAB GOVITECANO [200 MG; PÓ CONC SOL INJ; FRS]

SACITUZUMAB GOVITECANO [200 MG; PÓ CONC SOL INJ; FRS] SACITUZUMAB GOVITECANO [200 MG; PÓ CONC SOL INJ; FRS]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0481-SACITUZUMAB GOVITECANO [200 MG; PÓ CONC SOL INJ; FRS]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000249
Publication:
July 16, 2025, 8:21 a.m.
2023/0491 - CETUXIMAB [5 MG/ML;20 ML; FRS]

CETUXIMAB [5 MG/ML;20 ML; FRS] CETUXIMAB [5 MG/ML;20 ML; FRS]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491 - CETUXIMAB [5 MG/ML;20 ML; FRS]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000141
Publication:
July 16, 2025, 8:13 a.m.
Dostawa produktów leczniczych

Zamówienie obejmuje dostawę produktów leczniczych opisanych w 32 pakietach. Pakiet 1 Środki immunosupresyjne (program lekowy) Pakiet 2 Środki immunosupresyjne (program lekowy) Pakiet 3 Środki przeciwnowotworowe i immunomodulacyjne (program lekowy) Pakiet 4 Środki przeciwnowotworowe i immunomodulacyjne (program lekowy) Pakiet 5 Środki immunosupresyjne (program lekowy) Pakiet 6 Środki przeciwnowotworowe (chemioterapia) Pakiet 7 …

CPV: 33124130 Diagnostic supplies, 33600000 Pharmaceutical products, 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system, 33621200 Antihaemorrhagics, 33621300 Antianaemic preparations, 33651100 Antibacterials for systemic use, 33652000 Antineoplastic and immunomodulating agents, 33652100 Antineoplastic agents, 33652300 Immunosuppressive agents, 33661000 Medicinal products for the nervous system, 33661100 Anaesthetics, 33662100 Ophthalmologicals, 33692200 Parenteral nutrition products, 33692500 Injectable solutions, 33692800 Dialysis solutions, 33694000 Diagnostic agents, 33696000 Reagents and contrast media
Place of execution:
Dostawa produktów leczniczych
Awarding body:
4. Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej we Wrocławiu
Award number:
4WSzKzP.SZP.2612.21.2025
Publication:
July 16, 2025, 8:09 a.m.
2023/0491 - POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS]

POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS] POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS]

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
2023/0491 - POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000149
Publication:
July 16, 2025, 8:05 a.m.
Medicamente oncologice II - 6 loturi

Acord cadru furnizare medicamente diverse . Autoritatea contractantă va raspunde în mod clar și complet tuturor solicitarilor de clarificare/informatiilor suplimentare, in a 11-a zi inainte de termenul limita de depunere a ofertelor/candidaturilor (raspunsurile clare si complete ale tuturor solicitarilor de clarificare se vor atasa in a 11-a zi inainte de …

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
Medicamente oncologice II - 6 loturi
Awarding body:
Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"
Award number:
4364594202531
Publication:
July 15, 2025, 10:37 a.m.
Antineoplastika a imunomodulátory 2025

Předmětem veřejné zakázky jsou dodávky léčivých přípravků určených pro terapii závažných chronických onemocnění v celkovém předpokládaném objemu 181 760 jednotlivých dávek léčivých přípravků. Přípravky jsou určeny pro poskytování zdravotní péče na zdravotnických pracovištích FN Plzeň. Dodávky předmětu plnění budou realizovány na základě výsledků ukončeného zadávacího řízení po dobu čtyř let …

CPV: 33652000 Antineoplastic and immunomodulating agents
Deadline:
Aug. 12, 2025, 9 a.m.
Deadline type:
Submitting a bid
Place of execution:
Antineoplastika a imunomodulátory 2025
Awarding body:
Fakultní nemocnice Plzeň
Award number:
41/25
Publication:
July 15, 2025, 8:49 a.m.
251A000052 - XII - C.Central Medicamentos 2025-1310/2025 (Lotes 24 e 26)

C.Central Medicamentos 2025-1310/2025 (Lotes 24 e 26) USTECINUMAB 45 MG SOL INJ BIOSSIMILAR SERINGA (IMULDOSA) USTECINUMAB 90 MG SOL INJ BIOSSIMILAR SERINGA (IMULDOSA)

CPV: 33652000 Antineoplastic and immunomodulating agents
Place of execution:
251A000052 - XII - C.Central Medicamentos 2025-1310/2025 (Lotes 24 e 26)
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251A000052
Publication:
July 11, 2025, 11:07 a.m.
Medicamente diverse- 10 loturi

Acord cadru furnizare medicamente diverse . Autoritatea contractantă va raspunde în mod clar și complet tuturor solicitarilor de clarificare/informatiilor suplimentare, in a 11-a zi inainte de termenul limita de depunere a ofertelor/candidaturilor (raspunsurile clare si complete ale tuturor solicitarilor de clarificare se vor atasa in a 11-a zi inainte de …

CPV: 33600000 Pharmaceutical products, 33651630 BCG vaccines (dried), 33622600 Beta-blocking agents, 33651100 Antibacterials for systemic use, 33652000 Antineoplastic and immunomodulating agents
Place of execution:
Medicamente diverse- 10 loturi
Awarding body:
Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila"
Award number:
4364594202528
Publication:
July 11, 2025, 10:21 a.m.
Προσφορά για την προμήθεια Avapritinib, Capivasertib, Futibatinib και Sargramostim, Αρ. Διαγωνισμού: Φ.Υ.Υ. 103/2025 ΥΥ, Αρ. Φακ. Φ.Υ.Υ.13.25.02.08.239

Προμήθεια Avapritinib, Capivasertib, Futibatinib και Sargramostim, Αρ. Διαγωνισμού: Φ.Υ.Υ. 103/2025 ΥΥ, Αρ. Φακ. Φ.Υ.Υ.13.25.02.08.239 Προμήθεια Avapritinib, Capivasertib, Futibatinib και Sargramostim, Αρ. Διαγωνισμού: Φ.Υ.Υ. 103/2025 ΥΥ, Αρ. Φακ. Φ.Υ.Υ.13.25.02.08.239 Προμήθεια Avapritinib, Capivasertib, Futibatinib και Sargramostim, Αρ. Διαγωνισμού: Φ.Υ.Υ. 103/2025 ΥΥ, Αρ. Φακ. Φ.Υ.Υ.13.25.02.08.239 Προμήθεια Avapritinib, Capivasertib, Futibatinib και Sargramostim, Αρ. Διαγωνισμού: …

CPV: 33652000 Antineoplastic and immunomodulating agents
Deadline:
Aug. 14, 2025, 1 p.m.
Deadline type:
Submitting a bid
Place of execution:
Προσφορά για την προμήθεια Avapritinib, Capivasertib, Futibatinib και Sargramostim, Αρ. Διαγωνισμού: Φ.Υ.Υ. 103/2025 ΥΥ, Αρ. Φακ. Φ.Υ.Υ.13.25.02.08.239
Awarding body:
Υπουργείο Υγείας
Award number:
Αρ. Διαγωνισμού: Φ.Υ.Υ. 103/2025 ΥΥ , Αρ. Φακ. Φ.Υ.Υ.13.25.02.08.239
Publication:
July 11, 2025, 9:20 a.m.